BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 3, 2001
View Archived Issues
GSK issues product pipeline update
Read More
Biomira suspends two cancer vaccine programs to focus on advanced products
Read More
Dalbavancin to be developed as the first once-weekly injectable antibiotic
Read More
Lymphatic agent Tc-mannosyl-dextran undergoes clinical study in melanoma patients
Read More
Dyax acquires exclusive rights to develop antibody drugs aimed at angiogenesis target
Read More
Age limit lowered for participation in phase II trial of tgAAVCF in cystic fibrosis
Read More
Zenapax enters phase II trial in patients with chronic asthma
Read More
Prescient NeuroPharma and Access Oncology sign letter of intent for anhydrovinblastine
Read More
DMXAA increases the antitumor effect of radiotherapy and exerts antitumor activity on its own
Read More
Medicure seeks phase II clearance in U.S. and Canada for MC-1
Read More
Canadian approval for Fludara as NHL treatment
Read More
SB-265610: a nonpeptide CXCR2 antagonist effective against neutrophil accumulation
Read More
Class III antiarrhythmics from Merck KGaA prolong APD by blocking rapid delayed rectifier current
Read More
Synthetic heat shock protein-derived peptide appears to arrest progression of type 1 diabetes
Read More
Active vaccination against IL-5 as a novel approach to asthma
Read More
FDA marketing approval granted for improved form of Ritalin for ADHD
Read More
First IL-1 receptor antagonist now available for treatment of rheumatoid arthritis
Read More
Ivax immunotoxin for brain cancer reportedly effective at very low intratumoral doses
Read More
Geron telomerase inhibitor effective against particularly aggressive human tumors in mice
Read More
FDA clears injectable antibiotic Invanz
Read More
Novel compounds for CNS disorders, including stroke and ALS
Read More
Blood glucose-lowering glycosides designed by Kotobuki
Read More
Isoquinoline series with agonist activity at beta3-adrenoceptors
Read More
Nippon Kayaku isolates antitumor substances from Streptomyces
Read More
New MCP-1 receptor antagonists and uses thereof claimed by Daiichi
Read More
3-D presents thiazole-based PAI-1 inhibitors
Read More
Banyu patents selective muscarinic M3 receptor antagonists
Read More